ticlopidine has been researched along with Esophageal Perforation in 1 studies
Ticlopidine: An effective inhibitor of platelet aggregation commonly used in the placement of STENTS in CORONARY ARTERIES.
ticlopidine : A thienopyridine that is 4,5,6,7-tetrahydrothieno[3,2-c]pyridine in which the hydrogen attached to the nitrogen is replaced by an o-chlorobenzyl group.
Esophageal Perforation: An opening or hole in the ESOPHAGUS that is caused by TRAUMA, injury, or pathological process.
| Excerpt | Relevance | Reference |
|---|---|---|
| " In study 2, 35 healthy subjects were treated with LDA 100 mg (regimen A), and then 20 randomly selected subjects were dosed clopidogrel 75 mg (regimen C), LDA/clopidogrel (regimen AC), or LDA/clopidogrel/rabeprazole 10 mg for 7 days." | 1.39 | Antiplatelet drugs are a risk factor for esophageal mucosal injury. ( Furuta, T; Miyajima, H; Nishino, M; Osawa, S; Sahara, S; Sugimoto, K; Sugimoto, M; Umemura, K; Uotani, T; Watanabe, H; Yamada, T; Yamade, M, 2013) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sugimoto, M | 1 |
| Uotani, T | 1 |
| Nishino, M | 1 |
| Yamade, M | 1 |
| Sahara, S | 1 |
| Yamada, T | 1 |
| Osawa, S | 1 |
| Sugimoto, K | 1 |
| Umemura, K | 1 |
| Watanabe, H | 1 |
| Miyajima, H | 1 |
| Furuta, T | 1 |
1 other study available for ticlopidine and Esophageal Perforation
| Article | Year |
|---|---|
Antiplatelet drugs are a risk factor for esophageal mucosal injury.
Topics: Aged; Aged, 80 and over; Aryl Hydrocarbon Hydroxylases; Aspirin; Case-Control Studies; Clopidogrel; | 2013 |